6535 順藥歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 84.59% | -5099.72% | -6879.72% | -6879.72% |
| 2025Q1 | 58.34% | -1196.37% | -1184.84% | -1184.84% |
| 2024Q4 | 43.15% | -582.20% | -775.23% | -775.23% |
| 2024Q3 | 43.26% | -1378.96% | -3632.25% | -3632.25% |
| 2024Q2 | 59.10% | -858.53% | 770.73% | 770.73% |
| 2024Q1 | 30.90% | -1812.03% | -2634.80% | -2634.80% |
| 2023Q4 | 79.53% | -582.50% | -647.25% | -647.25% |
| 2023Q3 | 86.22% | -526.51% | -750.06% | -751.58% |
| 2023Q2 | 79.84% | -774.09% | -1073.52% | -1073.52% |
| 2023Q1 | 17.90% | -910.13% | 1804.88% | 1804.88% |
| 2022Q4 | 66.96% | -432.76% | 207.77% | 207.77% |
| 2022Q3 | 53.77% | -1819.54% | -3371.50% | -3372.29% |
| 2022Q2 | 29.86% | -2054.72% | -3975.95% | -3975.95% |
| 2022Q1 | 36.49% | -2128.09% | -6595.60% | -6595.60% |
| 2021Q4 | 80.86% | -1488.23% | -3260.46% | -3260.46% |
| 2021Q3 | 29.18% | -16279.02% | 73957.88% | 73957.88% |
| 2021Q2 | 22.54% | -2128.36% | -2583.67% | -2583.67% |
| 2021Q1 | 25.27% | -3660.39% | 2918.19% | 2918.19% |
| 2020Q4 | 61.49% | -534.44% | -627.47% | -627.47% |
| 2020Q3 | 205.64% | -6265.93% | -3388.43% | -3388.43% |
| 2020Q2 | 28.63% | -1578.27% | -1785.54% | -1785.54% |